The interaction of CD103 with E-cadherin on tumor cells optimizes cytokine release in CD8+ T cells, since siRNA targeting E-cadherin partially inhibits IFN-γ and granzyme B production (Franciszkiewicz et al., 2013). The gene discussed is ITGAE; the disease is neoplasm.